Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001658247

SEC filings (opens in a new tab)

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Crinetics Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of CRNX: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	140	1	172	+33
Shares	54.1M	78.5K	68.5M	+14.5M (+26.9%)
Value	$974.1M	$1.42M	$2.04B	+$1.07B (+109.5%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (52)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CRNX in Q3 2023
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	4,225,300	$125.7M	0.43%
Cormorant Asset Management, LP	1,101,904	$32.8M	1.91%
Avidity Partners Management LP	610,000	$18.1M	0.73%
Commodore Capital LP	500,000	$14.9M	1.74%
Affinity Asset Advisors, LLC	450,000	$13.4M	4.37%
Farallon Capital Management, L.L.C.	361,904	$10.8M	0.06%
Vivo Capital, LLC	350,000	$10.4M	1.29%
Laurion Capital Management LP	346,637	$10.3M	0.27%
Schonfeld Strategic Advisors LLC	277,208	$8.24M	0.08%
Logos Global Management LP	250,000	$7.43M	1.06%
Silverarc Capital Management, LLC	220,000	$6.54M	2.44%
Integral Health Asset Management, LLC	200,000	$5.95M	0.84%
Renaissance Technologies LLC	163,700	$4.87M	0.01%
Woodline Partners LP	150,000	$4.46M	0.05%
Simplify Asset Management Inc.	115,000	$3.42M	0.56%
Ghost Tree Capital, LLC	101,443	$3.02M	1.46%
Parkman Healthcare Partners LLC	100,000	$2.97M	0.54%
Ghisallo Capital Management LLC	100,000	$2.97M	0.30%
EAM Investors, LLC	94,189	$2.80M	0.54%
Acuta Capital Partners, LLC	94,000	$2.80M	2.03%
Alyeska Investment Group, L.P.	69,502	$2.07M	0.01%
Moody Aldrich Partners LLC	61,979	$1.84M	0.35%
Voloridge Investment Management, LLC	51,629	$1.54M	0.01%
Lisanti Capital Growth, LLC	49,980	$1.49M	0.23%
Jump Financial, LLC	47,476	$1.41M	0.05%
Victory Capital Management Inc	44,990	$1.34M	0.00%
Nomura Holdings Inc	31,720	$943.4K	0.01%
Man Group plc	–	$904.3K	0.00%
Marshall Wace, LLP	29,500	$877.3K	0.00%
Monashee Investment Management LLC	27,371	$814.0K	0.34%
FORA Capital, LLC	25,777	$766.6K	0.07%
SEI Investments Co	25,390	$755.1K	0.00%
Atom Investors LP	17,893	$532.1K	0.12%
AWM Investment Company, Inc.	15,000	$446.1K	0.07%
Zimmer Partners, LP	15,000	$446.1K	0.01%
GTS Securities LLC	13,874	$412.6K	0.01%
E Fund Management Co., Ltd.	10,155	$302.0K	0.02%
Group One Trading, L.P.	8,229	$244.7K	0.01%
Glenmede Trust Co NA	7,518	$223.6K	0.00%
Hudson Bay Capital Management LP	7,500	$223.1K	0.00%
Kestra Advisory Services, LLC	7,431	$221.0K	0.00%
Trexquant Investment LP	7,411	$220.4K	0.01%
Sandia Investment Management LP	5,000	$148.7K	0.04%
Cutler Group LP	4,800	$142.0K	0.02%
Belvedere Trading LLC	3,404	$101.2K	0.01%
Hunting Hill Global Capital, LLC	1,769	$52.6K	0.02%
Lindbrook Capital, LLC	49	$1.46K	0.00%
Allworth Financial LP	48	$1.43K	0.00%
EverSource Wealth Advisors, LLC	41	$1.22K	0.00%
Federated Hermes, Inc.	24	$714	0.00%
Russell Investments Group, Ltd.	14	$416	0.00%
Cornerstone Planning Group LLC	4	$119	0.00%

Sold out (19)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CRNX in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Finepoint Capital LP	797,527	$14.4M
Braidwell LP	650,312	$11.7M
Adage Capital Partners GP, L.L.C.	225,000	$4.05M
Norges Bank	149,100	$2.69M
Qube Research & Technologies Ltd	55,798	$1.01M
Cubist Systematic Strategies, LLC	47,192	$850.4K
HighVista Strategies LLC	32,623	$587.9K
Cantor Fitzgerald, L. P.	32,562	$586.8K
Balyasny Asset Management LLC	29,089	$524.2K
Ergoteles LLC	22,839	$411.6K
First Republic Investment Management, Inc.	19,354	$348.8K
Moore Capital Management, LP	17,117	$308.4K
Mackenzie Financial Corp	14,909	$269.0K
HSBC Holdings PLC	12,327	$225.2K
Dynamic Technology Lab Private Ltd	10,442	$188.0K
Aquatic Capital Management LLC	3,900	$70.0K
Harbor Capital Advisors, Inc.	1,150	$20.7K
CarsonAllaria Wealth Management, Ltd.	190	$3.42K
Versant Capital Management, Inc	31	$559

Not filed for Q3 2023 yet (1)

Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRNX in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Tekla Capital Management LLC	78,529	$1.42M